Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot
Code deleted, to report see 67299

Official Description

Destruction of macular drusen, photocoagulation

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 0017T refers to the procedure known as the destruction of macular drusen through photocoagulation. Macular drusen are small yellow or white accumulations of extracellular material that develop between the retina and the retinal pigment epithelium, often associated with age-related macular degeneration (AMD). These drusen can lead to vision impairment by affecting the retinal pigment epithelium, which is crucial for the health of photoreceptors in the retina. The procedure involves the use of a laser to precisely target and destroy these drusen, thereby potentially improving or stabilizing vision. During the procedure, the ophthalmologist carefully administers photocoagulation, ensuring that the fovea—the central part of the retina responsible for sharp vision—is avoided to minimize the risk of damage to this critical area. This technique is particularly important in managing patients with AMD, as it aims to reduce the progression of the disease and preserve visual function.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The procedure described by CPT® Code 0017T is indicated for the treatment of macular drusen, which are associated with age-related macular degeneration (AMD). The presence of these drusen can lead to visual disturbances and may progress to more severe forms of AMD, resulting in significant vision loss. The primary indications for performing this procedure include:

  • Age-Related Macular Degeneration (AMD) The presence of macular drusen as a feature of AMD, which can lead to vision impairment.
  • Visual Disturbances Symptoms such as blurred vision or difficulty in seeing fine details that may arise due to the accumulation of drusen.
  • Progression of Disease The need to prevent the progression of AMD and the associated risk of developing more severe retinal complications.

2. Procedure

The procedure for the destruction of macular drusen using photocoagulation involves several key steps, which are detailed as follows:

  • Step 1: Patient Preparation The patient is positioned comfortably, and the ophthalmologist ensures that the eye is adequately anesthetized to minimize discomfort during the procedure. A dilating agent may be used to widen the pupil, allowing for better visualization of the retina.
  • Step 2: Laser Setup The ophthalmologist prepares the laser equipment, selecting the appropriate settings for the photocoagulation treatment. This includes adjusting the laser's wavelength and power to effectively target the macular drusen while protecting surrounding retinal tissue.
  • Step 3: Targeting the Drusen Using a specialized lens, the ophthalmologist focuses the laser on the areas of the retina where the macular drusen are located. Care is taken to avoid the fovea, as damage to this area can lead to significant vision loss.
  • Step 4: Photocoagulation Application The ophthalmologist administers the laser treatment, delivering precise bursts of energy to the drusen. This energy causes the drusen to be destroyed, facilitating their absorption and reducing their impact on the retinal structure.
  • Step 5: Post-Procedure Assessment After the laser application, the ophthalmologist assesses the patient's response to the treatment and monitors for any immediate complications. Follow-up care instructions are provided to ensure proper recovery.

3. Post-Procedure

Following the photocoagulation procedure for the destruction of macular drusen, patients may experience some temporary discomfort or visual disturbances, which are typically mild and resolve within a short period. It is essential for patients to follow the ophthalmologist's post-procedure care instructions, which may include the use of anti-inflammatory eye drops to reduce inflammation and promote healing. Patients are advised to avoid strenuous activities and protect their eyes from bright lights for a specified duration. Regular follow-up appointments are crucial to monitor the effectiveness of the treatment and to assess any changes in vision or retinal health. The ophthalmologist will evaluate the need for additional treatments based on the patient's recovery and the progression of their condition.

Short Descr PHOTOCOAGULAT MACULAR DRUSEN
Medium Descr DSTRJ MACULAR DRUSEN PC
Long Descr Destruction of macular drusen, photocoagulation
Status Code Carriers Price the Code
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 0 - Physician Service Code
Multiple Procedures (51) 2 - Standard payment adjustment rules for multiple procedures apply.
Bilateral Surgery (50) 1 - 150% payment adjustment for bilateral procedures applies.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 0 - Payment restriction for assistants at surgery applies to this procedure...
Co-Surgeons (62) 0 - Co-surgeons not permitted for this procedure.
Team Surgery (66) 0 - Team surgeons not permitted for this procedure.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Significant Procedure, Multiple Reduction Applies
Type of Service (TOS) 2 - Surgery
Berenson-Eggers TOS (BETOS) none
MUE Not applicable/unspecified.
CCS Clinical Classification 17 - Destruction of lesion of retina and choroid
Date
Action
Notes
2011-01-01 Deleted Code deleted, to report see 67299
2002-01-01 Added Code added.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"